GLPcompareGLPcompare
DrugsPricesCompareShortagesEvidenceSupplementsWatchlist
HomeManufacturersEli Lilly
Manufacturer

Eli Lilly GLP-1 medications

GLP-1 medications from Eli Lilly, with sourced prices, shortage reports and study results.

Last checked · Oct 3, 2026 UTC
3approved
2in development

Approved medicines

Alphabetical by active ingredient. Approved uses depend on the specific brand and formulation.

GLP-1

Dulaglutide

Trulicity

Subcutaneous injection · Once weekly

FDA shortage report

Published entry quote

from $389/28 days

Trulicity single-dose pens · LillyDirect (Eli Lilly)

Checked Sep 30, 2026

Price conditions

self-pay, four weekly pens; published starting rate at each dose

The self-pay program requires a prescription for an approved use, age 18+, and US or Puerto Rico residence. Purchases cannot be submitted to insurance or counted toward deductibles or out-of-pocket limits. Four once-weekly pens cover 28 days.

28-day supply

Checked Sep 30, 2026. Entry quotes are not estimates of ongoing treatment cost.

Prices, evidence & safety
Small-molecule GLP-1

Orforglipron

Foundayo

Oral tablet (any time of day, no food or water restriction) · Once daily

FDA shortage report

Published entry quote

from $149/mo

Foundayo (LillyDirect self-pay) · LillyDirect (Eli Lilly)

Checked Sep 30, 2026

Price conditions
GIP/GLP-1

Tirzepatide

Mounjaro, Zepbound

Subcutaneous injection · Once weekly

FDA shortage report

Published entry quote

$299-$449/28 days

Zepbound KwikPen (multi-dose pen) · LillyDirect (Eli Lilly)

Checked Sep 30, 2026

Price conditions

Investigational (pipeline)

Alphabetical by active ingredient. These entries are not FDA-approved for this category; open a record for the studied uses and evidence.

GLP-1/glucagonApproved in China; not FDA-filed

Mazdutide

Mazdutide (investigational in US)

Subcutaneous injection · Once weekly

Investigational. No FDA-approved purchase option.

Study evidence & development
Triple agonistPhase 3
Other manufacturers
Novo Nordisk4AstraZeneca1Altimmune1Amgen1Boehringer Ingelheim1Innovent Biologics1Structure Therapeutics1Viking Therapeutics1Zealand Pharma1All GLP-1 drugs
GLPcompare is an informational data platform, not a medical provider or pharmacy. Nothing here is medical advice, a diagnosis, or a recommendation to start, stop, or change any treatment. Data is aggregated from public sources and can be incomplete or out of date. Always confirm with a licensed clinician and the current FDA label.
GLPcompareGLPcompare

The live, fully-cited reference for the GLP-1 ecosystem. Every figure traces to its source. Informational only, not medical advice.

Product

  • Drugs
  • Prices
  • Compare
  • Shortages
  • Evidence
  • Supplements

Legal

  • Methodology
  • About
  • News
  • Price updates
  • Privacy Policy
  • Terms of Service
  • Support

Some outbound links on GLPcompare are referral links. If you sign up or buy through one, we may earn a commission at no extra cost to you. It never changes the price you pay or the underlying data. Partner status and commission rates contribute to offer and provider value scores and can change their order. Every partner is labeled. Value scores are not medical recommendations; a higher-ranked offer is not necessarily the lowest price or the right product for you.

© 2026 GLPcompare. All rights reserved.

Fazier

self-pay cash, lowest dose; ~$25/mo with commercial coverage

The first oral small-molecule GLP-1 pill for weight loss; FDA-approved April 2026. LillyDirect self-pay ladder: $149 (0.8 mg), $199 (2.5 mg), $299 (5.5 and 9 mg), $299 (14.5 and 17.2 mg with a 45-day refill, else $349); the 2.5 mg and 5.5 mg doses are temporarily $149 and $199 through Dec 31, 2026.

30-day supply

Checked Sep 30, 2026. Entry quotes are not estimates of ongoing treatment cost.

Prices, evidence & safety

self-pay cash, by dose ($299 / $399 / $449)

Four weekly doses per pen; pen needles must be purchased separately. $299 at 2.5 mg, $399 at 5 mg, and $449 at higher doses under the Self Pay Journey offer with a refill within 45 days.

28-day supply

Checked Sep 30, 2026. Entry quotes are not estimates of ongoing treatment cost.

Prices, evidence & safety

Retatrutide

Retatrutide (investigational)

Subcutaneous injection · Once weekly

Investigational. No FDA-approved purchase option.

Study evidence & development
Browse
IndicationsDrug classesCompare head-to-head